Bausch + Lomb (BLCO) | Stock Overview & Key Data
Bausch + Lomb Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $21.95 on June 26, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bausch + Lomb
BLCO
|
5.64B Mid-cap | -1.19% | -6.77% | -9.04% | -12.23% | -9.53% | 22.30% | -23.06% | 104.06% | 166.90% | 56.92% | 56.92% |
|
Intuitive Surgical
ISRG
|
170.06B Large-cap | -0.49% | -1.09% | -13.84% | -25.55% | -25.88% | -19.74% | 24.81% | 40.32% | 476.52% | 974.11% | 3,431.44% |
| 56.10B Large-cap | -2.98% | 1.43% | -9.20% | -7.49% | -5.04% | 8.01% | -28.08% | -20.73% | 15.00% | 123.99% | 212.28% | |
| 9.38B Mid-cap | 8.16% | 20.29% | 21.84% | 6.55% | 6.72% | -31.87% | -54.01% | -74.19% | -53.06% | -34.17% | 1.07% | |
|
AptarGroup
ATR
|
7.99B Mid-cap | 5.49% | 2.97% | -8.50% | -3.47% | -3.64% | -22.12% | 0.49% | -15.97% | 54.18% | 133.20% | 364.56% |
|
Repligen
RGEN
|
7.49B Mid-cap | 4.42% | 27.22% | 13.69% | -18.50% | -20.37% | 2.41% | -17.06% | -33.82% | 517.16% | 3,568.26% | 4,563.93% |
Ownership & Short Interest
Calculate Your Bausch + Lomb Investment Returns
Long-Term Investment Performance Analysis
Bausch + Lomb stock price in Aug 2016 was $5.37, A $1,000.00 lump sum investment in Bausch + Lomb made 9 years ago would be worth approximately $2,793.30 today, representing a strong return of 179.33%. This translates to an annualized return (CAGR) of 11.04%.
9 Years 9 Months Investment Scenario (Aug 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BLCO's 52-week high and low?
- In the last 52 weeks, Bausch + Lomb reached a high of $18.92 (on February 25, 2026) and a low of $11.44 (on June 18, 2025).
- What is the market cap and P/E ratio for BLCO?
- Curious about Bausch + Lomb's size and valuation? Its market capitalization stands at 5.64B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is 15.00.
- Does BLCO pay dividends? If so, what's the yield?
- As for dividends, Bausch + Lomb isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Bausch + Lomb's main competitors or similar companies to consider before investing?
When looking at Bausch + Lomb, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG170.06B Healthcare Medical Instruments & Supplies -19.74% 24.81% Becton, Dickinson
BDX56.10B Healthcare Medical Instruments & Supplies 8.01% -28.08% Baxter International
BAX9.38B Healthcare Medical Instruments & Supplies -31.87% -54.01% AptarGroup
ATR7.99B Healthcare Medical Instruments & Supplies -22.12% 0.49% Repligen
RGEN7.49B Healthcare Medical Instruments & Supplies 2.41% -17.06% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Bausch + Lomb Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Bausch + Lomb's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -5.39%, the Debt to Equity ratio from the most recent quarter is 80.46, and its Gross Profit Margin stands at 62.06%.
- What is the recent revenue and earnings growth for BLCO?
- Looking at Bausch + Lomb's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.80%, and quarterly earnings saw a YoY growth of 9.77%.
- How much of BLCO stock is held by insiders and institutions?
- Wondering who owns Bausch + Lomb stock? Company insiders (like executives and directors) hold about 87.57% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 11.53%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.